pindolol has been researched along with Peripheral Nerve Diseases in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Man in't Veld, AJ | 1 |
| Boomsma, F | 1 |
| Schalekamp, MA | 1 |
| McDevitt, DG | 1 |
2 other studies available for pindolol and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Effects of beta-adrenoceptor agonists and antagonists in patients with peripheral autonomic neuropathy.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Albuterol; Amyloidosis; Autonomi | 1982 |
Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Asthma; Bradycardia; Cardiac Output; Heart Fa | 1983 |